Results 231 to 240 of about 9,770,479 (402)

Effects of Non‐Aspirin Nonsteroidal Anti‐Inflammatory Drugs on Acute Intracerebral Hemorrhage

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite celecoxib, a cyclooxygenase‐2 inhibitor, promoting functional recovery from intracerebral hemorrhage (ICH) by reducing inflammation‐mediated perihematomal edema in rat models, the evidence of its effects on patient outcomes remains limited.
Shin‐Joe Yeh, Sung‐Chun Tang, Li‐Kai Tsai, Jiann‐Shing Jeng   +3 more
wiley   +1 more source

The Pattern of Adverse Drug Reaction Reporting at a Regional Pharmacovigilance Center in North India: A Retrospective Observational Study. [PDF]

Cureus
Gupta PK, Kaur J, Devi G, Chaudhary S, Maria J.   +4 more
europepmc   +1 more source

[STUDIES ON THE STABILITY OF DRUGS. IX. ON THE DEGRADATION MECHANISM OF GLUCURONAMIDE. (1). REACTION AND EQUILIBRIUM BETWEEN GLUCURONIC ACID AND GLUCURONIC ACID LACTONE].

, 1964
Tsukinaka Yamana, Yoichi Mizukami, Shinichi Asahi   +2 more
openalex  

Adverse drug reactions. [PDF]

, 1981

openalex   +1 more source

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High‐Grade Gliomas: A Multicenter, Open‐Label Phase I Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang, Shenglan Li, Liang Wang, Qianxue Chen, Weiguo Hu, Ting Lei, Ying Mao, Jing Zhang, Xiaojun Xiang, Qiming Wang, Zhengwen He, Tao Sun, Yulei Wang, Mengqian Huang, Rong Zhang, Feng Chen, Wenbin Li   +16 more
wiley   +1 more source

Benralizumab in Corticosteroid-Refractory Drug Reaction With Eosinophilia and Systemic Symptoms: A Case Report. [PDF]

Cureus
Ross KR, Horesh E, Fang MM, Keller JJ.
europepmc   +1 more source

Adverse drug reactions checklist. [PDF]

, 1987
A H van Assendelft
openalex   +1 more source

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin, Gregory Sahagian, Marc H. Feinberg, C. Andrew Stewart, Christopher M. Jewell, Metin Kurtoglu, Miloš D. Miljković, Tuan Vu, Tahseen Mozaffar, James F. Howard Jr, the MG‐001 Study Group   +10 more
wiley   +1 more source

Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment. [PDF]

PLoS One
Chalabianloo N, Abdullah SS, Omrani MA, Jafari A, Sedig K, Muanda FT.   +5 more
europepmc   +1 more source

The appearance of macrophage migration-inhibition factor in drug reactions

, 1987
E Livni, S Halevy, Bettina Stahl, H Joshua   +3 more
openalex   +1 more source